Advanced search
Publication Cover
Future Oncology Volume 5, 2009 - Issue 7
Submit an article Journal homepage
312
Views
0
CrossRef citations to date
0
Altmetric
Special Report

PET/CT Imaging to Guide Cervical Cancer Therapy

Perry W GrigsbyMallinckrodt Institute of Radiology, Department of Radiation Oncology – Box 8224, Washington University School of Medicine, St Louis, MO63110, USA. [email protected]View further author information
Pages 953-958 | Published online: 30 Sep 2009

Bibliography

  • Wright JD , DehdashtiF, HerzogTJet al.: Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.Cancer104(11), 2484–2491 (2005).
  • Yen TC , NgKK, MaSYet al.: Value of dual-phase 2-fluoro-2-deoxy-D-glucose positron emission tomography in cervical cancer.J. Clin. Oncol.21(19), 3651–3658 (2003).
  • Rose PG , AdlerLP, RodriguezMet al.: Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.J. Clin. Oncol.17, 41–45 (1999).
  • Narayan K , HicksRJ, JoblingTet al.: A comparison of MRI and PET scanning in surgically staged loco-regional advanced cervical cancer: potential impact on treatment.Int. J. Gynecologic Cancer11, 263–271 (2001).
  • Reinhardt MJ , Ehritt-BraunC, VogelgesangDet al.: Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.Radiology218, 776–782 (2001).
  • Kuhnel G , HornLC, FischerUet al.: 18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings.Zentralbl Gynakol.123(4), 229–235 (2001).
  • Yeh LS , HungYC, ShenYYet al.: Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.Oncol. Rep.9(6), 1289–1292 (2002).
  • Lin WC , HungYC, YehLSet al.: Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.Gynecol. Oncol.89(1), 73–76 (2003).
  • Pandharipande PV , ChoyG, del CarmenMGet al.: MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.Am. J. Roentgenol.192(3), 802–814 (2009).
  • Landoni F , ManeoA, ColombAet al.: Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer.Lancet350, 535–540 (1997).
  • Park J-Y , KimEN, KimD-Yet al.: Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol. Oncol.108(3), 486–492 (2008).
  • Hricak H , GatsonisC, CoakleyFVet?al.: Early invasive cervical cancer: CT and MR imaging in preoperative evaluation – ACRIN/GOG comparative study of diagnostic performance and interobserver variability.Radiology245(2), 491–498 (2007).
  • Grills IS , YanD, BlackQC, WongC-YO, MartinezAA, KestinLL: Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.Int. J. Radiat. Oncol. Biol. Phys.67(3), 709–719 (2007).
  • Kruser TJ , BradleyKA, BentzenSMet al.: The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.Technol. Cancer Res. Treat.8(2), 149–158 (2009).
  • Nestle U , KrempS, GrosuA-L: Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.Radiother. Oncol.81(2), 209–225 (2006).
  • Topkan E , YavuzA, AydinM, OnalC, YaparF, YavuzM: Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma.J. Exp. Clin. Cancer Res.27(1), 41 (2008).
  • Deantonio L , BeldiD, GambaroGet al.: FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.Radiat. Oncol.3(1), 29 (2008).
  • Greco C , RosenzweigK, CasciniGL, TamburriniO: Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).Lung Cancer57(2), 125–134 (2007).
  • Morris M , EifelPJ, LuJet al.: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.N. Engl. J. Med.340(15), 1137–1143 (1999).
  • Beriwal S , GanGN, HeronDEet al.: Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.Int. J. Radiat. Oncol. Biol. Phys.68(1), 166–171 (2007).
  • Grigsby PW , HeydonK, MutchDG, KimRY, EifelPJ: Long-term follow-up of RTOG 92–10: cervical cancer with positive para-aortic lymph nodes.Int. J. Radiat. Oncol. Biol. Phys.51(4), 982–987 (2001).
  • MacManus M , NestleU, RosenzweigKEet al.: Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006–2007.Radiother. Oncol.91(1), 85–94 (2009).
  • Brunetti J , CaggianoA, RosenbluthB, VialottiC: Technical aspects of positron emission tomography/computed tomography fusion planning.Semin. Nucl. Med.38(2), 129–136 (2008).
  • Esthappan J , ChaudhariS, SantanamLet al.: Prospective clinical trial of PET/CT image-guided intensity-modulated radiation therapy for cervical carcinoma with postive para-aortic lymph nodes.Int. J. Radiat. Oncol. Biol. Phys.72(4), 1134–1139 (2008).
  • Schwarz JK , LinLL, SiegelBA, MillerTR, GrigsbyPW: 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.Int. J. Radiat. Oncol. Biol. Phys.72(5), 1502–1507 (2008).
  • Schwarz JK , SiegelBA, DehdashtiF, GrigsbyPW: Association of post-therapy positron emission tomography with tumor response and survival in cervical carcinoma.JAMA298(19), 2289–2295 (2007).
  • Bodurka-Bevers D , MorrisM, EifelP, LevenbackCet al.: Posttherapy surveillance of women with cervical cancer: an outcomes analysis.Gynecol. Oncol.78, 187–193 (2000).
  • Brooks RA , RaderJS, DehdashtiFet al.: Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.Gynecol. Oncol.112(1), 104–109 (2009).
  • Gregoire V , HaustermansK, GeetsX, RoelsS, LonneuxM: PET-based treatment planning in radiotherapy: a new standard?J. Nucl. Med.48(Suppl. 1), 68S–77S (2007).
  • Grosu AL , PiertM, WeberWAet al.: Positron emission tomography for radiation treatment planning.Strahlenther Onkol.181(8), 483–499 (2005).
  • Dolezelova H , SlampaP, OndrovaBet al.: The impact of PET with 18FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma: results of pilot study.Neoplasma55(5), 437–441 (2008).
  • S⊘vik Å, Malinen E, Olsen DR: Strategies for biologic image-guided dose escalation: a review. Int. J. Radiat. Oncol. Biol. Phys.73(3), 650–658 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.